A
Amar P. Dhillon
Researcher at University College London
Publications - 182
Citations - 14825
Amar P. Dhillon is an academic researcher from University College London. The author has contributed to research in topics: Liver transplantation & Cirrhosis. The author has an hindex of 60, co-authored 182 publications receiving 13953 citations. Previous affiliations of Amar P. Dhillon include Royal Free London NHS Foundation Trust & Kurume University.
Papers
More filters
Journal ArticleDOI
Hepatocytes from non-hepatic adult stem cells
Malcolm R. Alison,Richard Poulsom,Rosemary Jeffery,Amar P. Dhillon,Alberto Quaglia,Joseph Jacob,Marco Novelli,Grant Prentice,Jill Williamson,Nicholas A. Wright +9 more
TL;DR: This paper showed that adult human liver cells can be derived from stem cells originating in the bone marrow or circulating outside the liver, raising the possibility that blood-system stem cells could be used clinically to generate hepatocytes for replacing damaged tissue.
Journal ArticleDOI
Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia
Masamichi Kojiro,Ian R. Wanless,Venancio Avancini Ferreira Alves,Sunil Badve,Charles Balabaud,Pierre Bedosa,Prithi S. Bhathal,P. Bioulac-Sage,Elizabeth M. Brunt,Alastair D. Burt,John R. Craig,Amar P. Dhillon,Linda D. Ferrell,Stephen A. Geller,Zackary D. Goodman,Annette S.H. Gouw,Maria Guido,Maha Guindi,Prodromos Hytiroglou,Masayoshi Kage,Fukuo Kondo,Masutoshi Kudo,Gregory Y. Lauwers,Masayuki Nakano,Valérie Paradis,Young Nyun Park,Alberto Quaglia,Massimo Roncalli,Tania Roskams,Boris Ruebner,Michiie Sakamoto,Romil Saxena,Neil D. Theise,Swan Thung,Dina Taniakos +34 more
TL;DR: The International Consensus Group for Hepatocellular Neoplasia (ICGHN) was convened in April 2002 in Kurume, Japan and met several times up to July 2007 and this consensus document summarizes the results of the authors' meetings.
Journal ArticleDOI
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
Solko W. Schalm,Jenny Heathcote,J. Cianciara,G. Farrell,Mark E. Sherman,Bernard Willems,Amar P. Dhillon,AE Moorat,Judy Barber,DF Gray +9 more
TL;DR: The combination of lamivudine and interferon appeared to increase the HBeAg seroconversion rate, particularly in patients with moderately elevated baseline aminotransferase levels, and the potential benefit of combining lamivUDine andInterferon should be investigated further in studies with different regimens of combination therapy.
Journal ArticleDOI
A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability
Manuel Rodríguez-Perálvarez,Tu Vinh Luong,L. Andreana,Tim Meyer,Amar P. Dhillon,Andrew K. Burroughs +5 more
TL;DR: There is an urgent need to clarify this issue, because determining prognosis and response to therapy have become important in the current management of hepatocellular carcinoma, and a basis for consensus on its definition is presented.
Journal ArticleDOI
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.
Anthony J. Demetris,David H. Adams,Christopher Bellamy,Karin Blakolmer,Andrew D. Clouston,Amar P. Dhillon,John J. Fung,Annette S. H. Gouw,Bengt Gustafsson,Hironori Haga,David J. Harrison,John Hart,Stefan G. Hubscher,R. Jaffe,Urmila Khettry,Charles Lassman,Klaus J. Lewin,Olivia M. Martinez,Yuichi Nakazawa,Desley Neil,Orit Pappo,Maria Parizhskaya,Parmjeet Randhawa,Susanne Rasoul-Rockenschaub,Finn Reinholt,Michel Reynes,Marie E. Robert,Athanassios C. Tsamandas,Ian R. Wanless,Russell H. Wiesner,Annika Wernerson,Fritz Wrba,Judy Wyatt,Hirohiko Yamabe +33 more